Advertisement

Topics

"Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma" Drugs and Medication Database

01:27 EST 22nd February 2019 | BioPortfolio

Here are the most relevant "Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma" Drugs and Medications that we have found in our database.

More Information about "Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma" on BioPortfolio

We have published hundreds of Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma news stories on BioPortfolio along with dozens of Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma Clinical Trials and PubMed Articles about Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma Companies in our database. You can also find out about relevant Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma Drugs and Medications on this site too.

Showing "Genetic Study Patients With Acute Myeloid Leukemia Acute" Drugs and Medications 1–25 of 69

Probably Relevant

Venclexta [abbvie inc.]

These highlights do not include all the information needed to use VENCLEXTA safely and effectively. See full prescribing information for VENCLEXTA. VENCLEXTA (venetoclax tablets) for oral use Initial U.S. Approval: 2016

P32 sodium phosphate [anazaohealth corporation]

P32 Sodium Phosphate

Possibly Relevant

Imatinib mesylate [avpak]

Imatinib Mesylate Tablets These highlights do not include all the information needed to use IMATINIB MESYLATE TABLETS safely and effectively. See full prescribing information for IMATINIB MESYLATE TABLETS . IMATINIB MESYLATE tablets, for oral use Initial

Idarubicin hydrochloride [west-ward pharmaceuticals corp]

Idarubicin Hydrochloride Injection

Idarubicin hydrochloride [west-ward pharmaceuticals corp]

Idarubicin Hydrochloride Injection

Lynparza [astrazeneca pharmaceuticals lp]

These highlights do not include all the information needed to use LYNPARZA safely and effectively. See full prescribing information for LYNPARZA. LYNPARZA (olaparib) capsules, for oral useInitial U.S. Approval: 2014

Rubraca [clovis oncology, inc.]

These highlights do not include all the information needed to use RUBRACA safely and effectively. See full prescribing information for RUBRACA.RUBRACA (rucaparib) tablets, for oral useInitial U.S. Approval: 2016

Docetaxel [x-gen pharmaceuticals, inc.]

These highlights do not include all the information needed to use DOCETAXEL INJECTION USP (Injection Concentrate) safely and effectively. See full prescribing information for DOCETAXEL INJECTION USP (Injection Concentrate). DOCETAXEL Injection (Injection

Lynparza [astrazeneca pharmaceuticals lp]

These highlights do not include all the information needed to use LYNPARZA safely and effectively. See full prescribing information for LYNPARZA. LYNPARZA (olaparib) tablets, for oral useInitial U.S. Approval: 2014

Imatinib mesylate [apotex corp]

These highlights do not include all the information needed to use IMATINIB MESYLATE TABLETS safely and effectively. See full prescribing information for IMATINIB MESYLATE TABLETS .  IMATINIB MESYLATE tablets, for oral use Initial U.S. Approval: 2001

Mitoxantrone [fresenius kabi usa, llc]

MitoXANTRONE Injection, USP

Docetaxel [mylan institutional llc]

These highlights do not include all the information needed to use DOCETAXEL INJECTION safely and effectively. See full prescribing information for DOCETAXEL INJECTION. DOCETAXEL injection, for intravenous use Initial U.S. Approval: 1996

Docetaxel [mylan institutional llc]

These highlights do not include all the information needed to use DOCETAXEL INJECTION safely and effectively. See full prescribing information for DOCETAXEL INJECTION. DOCETAXEL INJECTION, for intravenous use Initial U.S. Approval: 1996

Docetaxel [mylan institutional llc]

These highlights do not include all the information needed to use DOCETAXEL INJECTION safely and effectively. See full prescribing information for DOCETAXEL INJECTION. DOCETAXEL injection, for intravenous use Initial U.S. Approval: 1996

Iclusig [millennium pharmaceuticals, inc.]

These highlights do not include all the information needed to use ICLUSIG safely and effectively. See full prescribing information for ICLUSIG. ICLUSIG(ponatinib) tablets, for oral use Initial U.S. Approval: 2012

Docetaxel [dr. reddy's laboratories inc.]

ONE-VIAL FORMULATION These highlights do not include all the information needed to use DOCETAXEL INJECTION safety and effectively. See full prescribing information for DOCETAXEL INJECTION. ONE- VIAL FORMULATION DOCETAXEL injection, for intravenous infusio

Sprycel [physicians total care, inc.]

These highlights do not include all the information needed to use SPRYCEL safely and effectively. See full prescribing information for SPRYCEL. SPRYCEL (dasatinib) Tablet for Oral Use Initial U.S. Approval: 2006

Aranesp [amgen inc]

These highlights do not include all the information needed to use ARANESP safely and effectively. See full prescribing information for ARANESP .     ARANESP (darbepoetin alfa )   i njection, for intravenous or subcutaneous use Initial U.S. Approval: 2

Idarubicin hydrochloride [teva parenteral medicines, inc.]

IDArubicin Hydrochloride Injection

Idamycin pfs [pharmacia and upjohn company llc]

Idamycin PFS idarubicin hydrochloride injection

Imatinib mesylate [american health packaging]

These highlights do not include all the information needed to use IMATINIB MESYLATE TABLETS safely and effectively. See full prescribing information for IMATINIB MESYLATE TABLETS. IMATINIB MESYLATE tablets, for oral use Initial U.S. Approval: 2001

Dexrazoxane [alvogen inc.]

These highlights do not include all the information needed to use DEXRAZOXANE FOR INJECTION safely and effectively. See Full Prescribing Information for DEXRAZOXANE FOR INJECTION. DEXRAZOXANE for injection for intravenous useInitial U.S. Approval: 1995

Dexrazoxane [breckenridge pharmaceutical, inc.]

These highlights do not include all the information needed to use DEXRAZOXANE FOR INJECTION safely and effectively. See Full Prescribing Information for DEXRAZOXANE FOR INJECTION. DEXRAZOXANE for injection for intravenous useInitial U.S. Approval: 1995

Imatinib mesylate [west-ward pharmaceuticals corp]

These highlights do not include all the information needed to use IMATINIB MESYLATE TABLETS safely and effectively. See full prescribing information for IMATINIB MESYLATE TABLETS. IMATINIB MESYLATE tablets, for oral useInitial U.S. Approval: 2001

Dexrazoxane [west-ward pharmaceuticals corp]

These highlights do not include all the information needed to use DEXRAZOXANE FOR INJECTION safely and effectively. See full prescribing information for DEXRAZOXANE FOR INJECTION. DEXRAZOXANE for Injection for [Route of Administration] use Initial U.S.



Advertisement
Quick Search
Advertisement
Advertisement